Literature DB >> 33875510

Severe metabolic ketoacidosis as a primary manifestation of SARS-CoV-2 infection in non-diabetic pregnancy.

Jojanneke Epke van Amesfoort1, Dominique E Werter2, Rebecca C Painter2, Frederik J R Hermans2.   

Abstract

We present a case of a metabolic acidosis in a term-pregnant woman with SARS-CoV-2 infection.Our patient presented with dyspnoea, tachypnoea, thoracic pain and a 2-day history of vomiting, initially attributed to COVID-19 pneumonia. Differential diagnosis was expanded when arterial blood gas showed a high anion gap metabolic non-lactate acidosis without hypoxaemia. Most likely, the hypermetabolic state of pregnancy, in combination with maternal starvation and increased metabolic demand due to infection, had resulted in metabolic ketoacidosis. Despite supportive treatment and rapid induction of labour, maternal deterioration and fetal distress during labour necessitated an emergency caesarean section. The patient delivered a healthy neonate. Postpartum, after initial improvement in metabolic acidosis, viral and bacterial pneumonia with subsequent significant respiratory compromise were successfully managed with oxygen supplementation and corticosteroids. This case illustrates how the metabolic demands of pregnancy can result in an uncommon presentation of COVID-19. © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  COVID-19; metabolic disorders; pregnancy

Year:  2021        PMID: 33875510     DOI: 10.1136/bcr-2021-241745

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  2 in total

1.  Starvation ketosis in a pregnant woman with COVID-19: a case report.

Authors:  Melanie Nana; Catherine Nelson-Piercy
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2022-06-01

2.  Euglycemic diabetic ketoacidosis and COVID-19: A combination to foresee in pregnancy.

Authors:  Inés Velasco; Berta Soldevila; Teresa Julián; Natalia García-Riaño; Manel Puig-Domingo
Journal:  J Diabetes       Date:  2021-11-19       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.